Compressive optic neuropathy caused by renal osteodystrophy. Case report. by Digre, Kathleen B.
PTIC nerve compression is a well-known cause of
both acute and chronic visual loss. Common caus-
es include tumors such as pituitary macroadeno-
mas, meningiomas, ON gliomas, and metastases, and trau-
ma to the frontal skull base involving the optic canal. Other
causes include aneurysms and hemorrhage, like that seen
in sickle cell disease.6,16,17,20 Graves disease may compro-
mise the ON at the orbital apex, secondary to hypertrophy
of the orbital muscles.3 Less commonly, ON compression
may be caused by osseous tumors of the sphenoid bone
or orbit.16,17 Osteopetrosis and fibrous dysplasia of the cen-
tral cranial base are well-known but uncommon causes of
chronic, and more rarely, acute vision loss.1,4,11 Compres-
sive optic neuropathy may respond to ON decompression,
especially if the vision loss is incomplete.
We present an unusual case of acute optic neuropathy
in which the patient had massive calvarial hypertrophy
caused by renal hyperparathyroidism. This hypertrophic
condition of the facial bones has recently been described in
the radiological literature as ULO, or “bighead” disease.15
It has not been associated previously with the development
of cranial neuropathy. 
Case Report
History. This 25-year-old woman with dialysis-depen-
dent renal failure was referred to the neuro-ophthalmolo-
gy clinic for evaluation of acute, painless vision loss in the
right eye. Vision loss began 6 days before presentation, but
she did not seek immediate clinical attention. 
Her medical history was significant for congenital bilat-
eral renal dysplasia and failed kidney transplants at 11 and
16 years of age. She started hemodialysis 6 months before
presentation after suffering multiple complications from
peritoneal dialysis. She had required a parathyroidectomy
at the age of 10 years for secondary hyperparathyroidism.
During this procedure, she had suffered a right frontal wa-
tershed infarction, with subsequent, well-controlled sei-
zures. She has chronic anemia, hypertension, and surgical-
ly corrected bone/joint growth abnormalities as a result
of her renal disease. She also suffers from asymptomatic
aortic insufficiency, chronic daily headache, and frequent
bouts of sinusitis.
Examination. On general examination, the patient was
found to be of small stature (5 ft 1 in, 45 kg), with a broad,
rounded head and small facial features. Neuroophthalmo-
logical examination at presentation revealed visual acuity
of 20/400 with no color vision OD, and 20/15 with normal
color vision OS. Pupils were reactive, with a profound
right RAPD of greater than 2.4 log U. Her right optic disc
was severely swollen, with retinal hemorrhages and ve-
nous congestion; her left was elevated, with no venous pul-
sations. Visual fields on the right revealed a large central
scotoma to confrontation, with only a small area in the
inferonasal quadrant in which she could count fingers. Ex-
traocular movements and all other cranial nerve functions
were normal. Results on the remainder of her ophthalmo-
logical examination were normal. The neurological exami-
nation was notable only for trace left proximal lower-ex-
tremity weakness and hyperreflexia. 
The small area of limited acuity in the inferonasal quad-
rant OD was confirmed on Goldmann visual fields (Fig.
1 upper). Ophthalmological color Doppler ultrasonogra-
phy examination revealed significantly diminished blood
flow in the right OphA. Retinal fluorescein angiography
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Abbreviations used in this paper: MR = magnetic resonance;
OD = right eye; ON = optic nerve; OphA = ophthalmic artery;
OS = left eye; RAPD = relative afferent pupillary defect; ULO =
uremic leontiasis ossea.
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FIG. 1. Goldmann visual fields at presentation (upper), after 3 days of treatment with high-dose methylprednisolone
(center), and 1 year (lower) after ON decompression. The initially small area of preserved vision enlarged significantly
after treatment with steroid drugs and remained improved after surgical treatment 1 year later. 
revealed normal flow times but significant capillary leak-
age in the right optic disc.
Neuroradiological Studies. Computerized tomography
scanning (Fig. 2) revealed diffuse hyperostosis resulting
in a thickened calvaria that measured up to 3 cm thick
in some areas; only the bisquamous occipital bone was
spared. All foramina were significantly narrowed, and the
right optic canal in particular was narrowed to less than 2
mm. Sinus spaces were nearly obliterated, and sinus mu-
cous membranes and meninges were diffusely thickened.
Sagittal MR imaging (Fig. 3) revealed multiple small, cir-
cumscribed lesions within the calvaria that were consistent
with brown tumors, characteristic of the hypererythropoie-
sis of chronic anemia. Also observed on MR imaging were
abnormal vascular flow voids in the anterior intracrani-
al region, and MR angiography revealed a moyamoya pat-
tern of collateral vascularization. Conventional angiogra-
phy demonstrated occlusion of the supraclinoidal segment
of the internal carotid arteries bilaterally, distal to the ori-
gin of the anterior choroidal artery, with collateral reconsti-
tution of the distal anterior and middle cerebral arteries.
The proximal and cavernous segments of the internal ca-
rotid arteries, and the OphAs, were normal on angiograph-
ic studies. 
Opening pressure on lumbar puncture was normal at 180
mm H2O. Cerebrospinal fluid chemistry and cell counts
were normal, and oligoclonal bands were negative. Serum
levels of sodium, potassium, bicarbonate, chloride, and
glucose were normal. Elevation of the following constitu-
ents were noted on serum studies: blood urea nitrogen 50
mg/dl (normal 7–20 mg/dl), creatinine 7 mg/dl (normal
0.7–1.1 mg/dl), calcium 9.5 mg/dl (normal 8.4–10.2 mg/
dl), phosphorus 5.5 mg/dl (normal 2.1–4.3 mg/dl), and
parathyroid hormone 701 pg/ml (normal 11–54 pg/ml).
Treatment and Clinical Course. The patient was admit-
ted and treated with intravenously administered high-dose
methylprednisolone (250 mg every 6 hours). Within 18
hours of starting treatment, her visual acuity had improved
subjectively, and within 3 days it had improved to 20/200.
The right central scotoma was reduced in size and she was
able to count fingers in all but the superonasal field (Fig. 1
center).
Because we were concerned that compression of the ON
within the optic canal was contributing at least in part to
her vision loss,23 we decided to proceed with surgical de-
compression of the canal via a right pterional craniotomy.
Care was taken throughout the surgery to avoid any hy-
potension. The bone thickness at the pterion was 2.5 cm,
which was well beyond the capability of conventional
drills and craniotomes, making entry somewhat challeng-
ing. This difficulty was surmounted using handheld burrs
and an oscillating saw to complete the cranial opening. The
ON and orbital roof were exposed by gentle elevation of
the frontal lobe intradurally, and the dorsal aspect of the
optic canal was completely opened using a burr (model
M8; Midas Rex Inc., Fort Worth, TX) with copious irriga-
tion, microcurette, and a 1-mm Kerrison rongeur. The bone
in this location was noted to be 10 mm thick, in contrast
with the usual thickness of 1 to 2 mm. The ON sheath was
R. H. Schmidt, et al.
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FIG. 2. Axial (left) and coronal (right) computerized tomography scans of the orbits revealing bone thickening and
overgrowth that was narrowing the optic canals (large arrows) and superior orbital fissures (small arrows) bilaterally.
The sinus mucosa is thickened. 
FIG. 3. Sagittal T1-weighted MR image revealing diffuse cal-
varial thickening. The hypointense areas in the marrow spaces rep-
resent areas of hypererythropoiesis or so-called brown tumors (ar-
rows). 
fenestrated with a scalpel and microscissors, and a distinct
pallor of the ON was noted.
Postoperative Course. The patient had an uneventful
postoperative course with further objective improvement
in her right visual field and color vision. Steroid medica-
tions were tapered after the 3rd postoperative day. Over the
next 12 months, the visual field of her right eye had im-
proved, with only a small central scotoma remaining (Fig.
1 lower). Her acuity remained stable at 20/200 OD, with
a 1.5 log U RAPD. She underwent evaluation for residual
parathyroid tissue, but none was found. 
Sixteen months after her initial presentation she suffered
acute painless vision loss of the left eye. Visual acuity was
20/400 OS, there was a 0.9 to 1.2 log U RAPD, and the
visual field was severely constricted. She sought clinical
treatment immediately after the onset of symptoms, and
treatment was begun with intravenously administered ste-
roids at the same dose as before for 5 days. This was then
followed by orally administered prednisone (60 mg/day).
With this treatment there was also significant improvement
in visual acuity, and ON decompression was not attempt-
ed. On subsequent visual examinations her acuity was 20/
200 OD and 20/30 OS, with a RAPD of 0.6 log U in the
left eye. A visual field examination conducted 28 months
after her initial presentation, however, showed a signifi-
cantly more constricted visual field in the left eye than in
the right (Fig. 4A), and at 40 months the visual field loss in
her left eye had increased further (Fig. 4B). 
Discussion
The massive calvarial hypertrophy encountered in this
patient fits best with a diagnosis of ULO or bighead dis-
ease, which has been known to affect animals with hyper-
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FIG. 4. Goldmann visual fields 28 months (upper) and 40 months (lower) after initial presentation, and after a similar
episode of acute left eye vision loss treated only with steroid drugs. The left eye shows persistent severe vision field loss,
which progressively worsens between studies obtained at 28 months and 40 months, whereas the visual field in the right
eye remains stable.
parathyroidism induced by diets chronically deficient in
calcium and rich in phosphate.14 It has also been seen in
animals with hyperparathyroidism secondary to chronic re-
nal insufficiency.19 Uremic leontiasis ossea represents an
extreme manifestation of renal osteodystrophy in the cal-
varia and facial bones. Lee, et al.,15 recently described the
clinical and radiographic features of ULO in five patients
and found only four previous descriptions of this entity in
humans.5,7,12,13,22 In these cases, maxillary and mandibu-
lar hypertrophy dominated the clinical presentation and led
to respiratory insufficiency, parotitis, dysphagia, or speech
impairment. In all the patients presented by Lee, et al.,
there was calvarial hypertrophy with marked expansion of
the diploic space and numerous diploic nodules typical of
brown tumors. The incidence of ULO is unknown, as is the
incidence of subclinical craniofacial hypertrophy in cases
of chronic uremia and secondary hyperparathyroidism. 
The calvarial hypertrophy and neuroforaminal stenosis
in our patient resembles the conditions of fibrous dysplasia
and osteopetrosis. These two entities commonly present
with compressive cranial neuropathies, especially of the
second, seventh, and eighth cranial nerves.1,4,10 Vision loss
with these two diseases is most commonly progressive, but
can be precipitous. The compressive optic neuropathy seen
in these two conditions is best treated with ON decompres-
sion.1,2,4,6,8–11,18,19,24 Improvement or stabilization of vision
has been achieved in 83 to 94% of patients with these dis-
orders who undergo ON decompression for subtotal vision
loss.1,4,20 Transient visual worsening after surgery was re-
ported in only one of 16 eyes. It is less clear whether de-
compressive surgery should be performed prophylactically
in patients with these two entities, although it is advocated
by some authors because of the low morbidity rate associ-
ated with this procedure.1,21 In cases of neoplasm, trauma
and fibrous dysplasia, visual outcome is better the less im-
paired vision is at the time of decompression.3,4,6,16,17,20 The
use of corticosteroid drugs as an adjunct to treatment of
vision loss in compressive optic neuropathy has not been
studied in a randomized controlled fashion, although they
tend to be widely used. In a recent metaanalysis of steroid
treatment compared with decompressive surgery for acute
traumatic optic neuropathy, similar outcomes were found
with either treatment or both together, and worse outcomes
were seen if neither treatment was used.6
A variety of surgical approaches are available for ON
decompression, including the transcranial approach used
here, and the transethmoidal approach. In this case the
transcranial approach was used because of the marked dis-
tortion of the skull base anatomy secondary to bone hyper-
trophy and the perceived advantage of being able to visu-
alize the ON directly in the suprasellar subarachnoid space
as it enters the optic canal. It is our opinion that with this
degree of bone thickening, the transethmoidal approach
would be extremely challenging. Regardless of the ap-
proach, it is essential to decompress the nerve along the en-
tire length of the optic canal and over an adequate width.
Most authors also advocate opening the dural sheath and
the annulus of Zinn to complete the decompression.4,16
This patient also had coincidental moyamoya disease
with bilateral occlusion of the supraclinoid segment of her
carotid arteries just distal to the origin of the anterior cho-
roidal arteries. Although this underlying disease also could
have contributed to the patient’s vision loss, the angiogram
revealed no abnormalities of the orbital vasculature includ-
ing the OphA. We believe that a combination of ischemia
and ON compression best account for this patient’s vision
loss.23 The abrupt onset of vision loss was fundamentally
ischemic in nature; however, the ON compression from the
bone overgrowth likely contributed to the nerve’s vascular
compromise. Thus, we believe that ON decompression is
justified for this condition.
Interestingly, with the subsequent episode of vision loss
involving the contralateral eye, the patient served as her
own control. The medically treated eye sustained progres-
sive visual field loss from 28 months to 40 months, and the
final examination 40 months after her initial presentation
showed a substantially worse visual field outcome in this
eye. The eye that did not undergo operation also ended up
with a larger RAPD than the one that did. The eye that was
nor surgically treated, however, did recover better visual
acuity with less impairment of the central fibers. This dif-
ference may be due to the fact that the patient sought oph-
thalmological treatment much sooner after the second epi-
sode of vision loss than after the first. 
Parathyroidectomy is recommended for treatment of pa-
tients with ULO, and it may stabilize the disease, although
the long-term outcome of these patients has not been deter-
mined.15 Patients with this disease should be considered to
be at risk of compressive cranial neuropathy, and appropri-
ate clinical monitoring should be performed on a regular
basis. Until a way is found to reverse the foraminal stenosis
medically, we suggest considering treating any compres-
sive cranial neuropathy in these patients with prompt sur-
gical decompression.
Conclusions
Calvarial hypertrophy in renal osteodystrophy, or ULO,
has not previously been described as a cause of ON com-
pression. When treated early and aggressively with high-
dose steroid medications and ON decompression, vision
loss can be significantly reversed. Without ON decompres-
sion, progressive loss of vision may occur.
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